 and their public health impact has evolved substantially since December 2020. Published reports from the original randomized placebo-controlled trials concluded that the MODEM mRNA injections could greatly reduce COVID-19 symptoms. However, the premature termination of both trials obviated any reliable assessment of potential adverse effects due to the insufficient timeframe